The drug lapatinib could be used to treat aggressive inflammatory breast cancer suggest the findings of a recent study. For patients resistant to conventional anthracycline or taxane and trastuzumab, treatment options are limited. Lapatinib inhibits… Continue reading
A unique mother-daughter study that used magnetic resonance to measure breast density in younger women shows that percent of breast water could be linked to the risk of breast cancer in middle age and… Continue reading
A recent study of risk factors for breast cancer in young women suggests risk assessment and prevention, using techniques that avoid radiation, such as MRI, should start much earlier in life. The study… Continue reading
